Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia. [electronic resource]
- Molecular therapy : the journal of the American Society of Gene Therapy 09 2016
- 1655-64 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural
1525-0024
10.1038/mt.2016.147 doi
Adenosine--pharmacology Adult Aged Aged, 80 and over Antigens, Neoplasm Cell Survival--drug effects Graft vs Host Disease--etiology Haplotypes Humans Immunity Leukemia--complications Lymphocyte Depletion Lymphocyte Subsets--drug effects Middle Aged T-Cell Antigen Receptor Specificity--immunology T-Lymphocytes--drug effects Tissue Donors Viruses--immunology Young Adult